Oppenheimer Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,079
| Closed | -$496K | – | 1186 |
|
|
2024
Q4 | $496K | Sell |
4,079
-378
| -8% | -$46K | 0.01% | 863 |
|
|
2024
Q3 | $557K | Buy |
4,457
+145
| +3% | +$18.1K | 0.01% | 853 |
|
|
2024
Q2 | $681K | Buy |
4,312
+708
| +20% | +$112K | 0.01% | 786 |
|
|
2024
Q1 | $467K | Buy |
3,604
+874
| +32% | +$113K | 0.01% | 851 |
|
|
2023
Q4 | $263K | Sell |
2,730
-1,003
| -27% | -$96.7K | ﹤0.01% | 1027 |
|
|
2023
Q3 | $453K | Buy |
3,733
+468
| +14% | +$56.7K | 0.01% | 872 |
|
|
2023
Q2 | $374K | Buy |
+3,265
| New | +$374K | 0.01% | 929 |
|
|
2021
Q1 | – | Sell |
-1,277
| Closed | -$218K | – | 1204 |
|
|
2020
Q4 | $218K | Sell |
1,277
-212
| -14% | -$36.2K | ﹤0.01% | 1057 |
|
|
2020
Q3 | $210K | Buy |
+1,489
| New | +$210K | ﹤0.01% | 1019 |
|
|
2020
Q2 | – | Sell |
-320
| Closed | -$32K | – | 1397 |
|
|
2020
Q1 | $32K | Sell |
320
-7
| -2% | -$700 | ﹤0.01% | 1330 |
|
|
2019
Q4 | $42K | Sell |
327
-2
| -0.6% | -$257 | ﹤0.01% | 1366 |
|
|
2019
Q3 | $25K | Buy |
329
+1
| +0.3% | +$76 | ﹤0.01% | 1438 |
|
|
2019
Q2 | $50K | Sell |
328
-28
| -8% | -$4.27K | ﹤0.01% | 1376 |
|
|
2019
Q1 | $42K | Sell |
356
-110
| -24% | -$13K | ﹤0.01% | 1381 |
|
|
2018
Q4 | $51K | Buy |
+466
| New | +$51K | ﹤0.01% | 1341 |
|
|
2017
Q4 | – | Sell |
-99
| Closed | -$4K | – | 1432 |
|
|
2017
Q3 | $4K | Buy |
+99
| New | +$4K | ﹤0.01% | 1592 |
|